Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Talk Parenting Education Program II

NCT07462052 · tracked via the Priya Life Science USA tracker
Sponsor
Oregon Research Behavioral Intervention Strategies, Inc
Phase
Not applicable
Started
2026-11-01
Last updated
2026-10-05

Condition(s) studied

Parenting PracticesSelf EfficacyStressChild BehaviorEmotional AdjustmentSleep ProblemParent-Child Relations

Investigational drug(s) / intervention(s)

The Talk Parenting Program

The Talk Parenting Program: In a 6-week session, families will use at home the Talk Parenting program, a smart speaker app designed to provide parents with in-situ experiential support for building positive family bedtime and morning routines. The Bedtime Routine, Morning Routine, and Calming Down Mini-Routine modules of Talk Parenting will guide families in creating healthy bedtime and morning routines to foster healthy sleep/wake habits, provide experiential practice in self-regulation skills, and promote a positive parent-child relationship.

Study summary

The goal of this clinical trial is to learn whether Talk Parenting, a voice-based program delivered through an Amazon Echo Dot (Alexa), can help parents and caregivers of children ages 3-5 years improve challenging bedtime and morning routines. The main questions it aims to answer are:

Does using Talk Parenting improve families' bedtime and morning experiences and children's sleep/wake habits?

Does using Talk Parenting improve parents' routine-related parenting practices and confidence, strengthen the parent-child relationship, and reduce children's behavior problems and parents' stress?

Researchers will compare families who receive Talk Parenting right away to families who wait 6 weeks to receive the program (a waitlist control group receiving usual services during the wait).

Participants will:

Complete online questionnaires at the start of the study and again about 6 weeks later (and a follow-up questionnaire later in the study).

Receive a pre-configured Amazon Echo Dot (to keep) and instructions to use Talk Parenting routines at home, including a bedtime routine, a brief calming routine, and a morning routine (enabled after the first 2 weeks).

Eligibility

Sex
ALL
Min age
3 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Referred by a participating agency * Child 3-5 years old who lives with the parent at least half time * The primary parent in the home (typically the mother but not always) * Speaks English * Has access to a computer, tablet, or mobile phone at home * Access to high-speed internet at home is desired but not required. The project will cover internet costs for a small number of participants if needed. The participating agencies all serve families who are low-income and/or experiencing economic hardship, stressful family relationships, children's behavior problems, or household instability; thus referred families will be experiencing one or more of these risk factors for an at-risk family environment. Exclusion Criteria: * Families of target-age children with a developmental disability severe enough that the child cannot speak or follow simple directions will be excluded * Families of target-age children whose needs are beyond the scope of Talk Parenting will be excluded

Primary outcome measure(s)

  • Short-Form Children's Sleep Habits Questionnaire (SF-CSHQ) — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    Children's bedtime/sleep problems will be measured with the Short-Form Children's Sleep Habits Questionnaire (SF-CSHQ), a 23-item version of the widely used CSHQ. Respondents answer on a 5-point scale (1=never; 5=always-7x/week); a mean score will be computed and can range from 1 to 5, with higher scores indicating worse outcomes.
  • Child Adjustment & Parent Self-Efficacy Scale (CAPES) : Behavioral Problems Subscale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    The Child Adjustment and Parent Efficacy Scale (CAPES) measures children's behaviors and emotional adjustment. The Behavior Problems subscale consists of 16 problematic and 8 reverse-coded positive behaviors. Respondents answer on a 4-point scale (0=Not at all; 3=Very much); the summed scores range from 0 to 72, with higher scores indicating worse outcomes.
  • Child Adjustment & Parent Self-Efficacy Scale (CAPES) : Emotional Maladjustment Subscale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    The Child Adjustment and Parent Efficacy Scale (CAPES) measures children's behaviors and emotional adjustment. The Emotional Maladjustment subscale has 3 items. Respondents answer on a 4-point scale (0=Not at all; 3=Very much); the summed scores range from 0 to 9, with higher scores indicating worse outcomes.
  • Child Adjustment & Parent Self-Efficacy Scale (CAPES) : Parent Self-Efficacy Subscale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    The Child Adjustment and Parent Efficacy Scale (CAPES) measures children's behaviors and emotional adjustment. The CAPES is also used to measure parents' self-efficacy; parents rate their confidence that they can successfully deal with each of the 19 negative behaviors/emotions on the CAPES. Respondents answer on a 10-point scale (1=Certain I can't do it; 10=Certain I can do it); the summed scores range from 19-190, with higher scores indicating better outcomes.
  • Self-Efficacy for Parenting Tasks Index - Toddler Scale (SEPTI-TS): Discipline Subscale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    The Self-Efficacy for Parenting Tasks Index - Toddler Scale - Short Form (SEPTI-TS-SF) is used to measure parents' self-efficacy for discipline- and routines-related parenting tasks. The Discipline subscale is measured with 6 items. Respondents answer on a 6-point scale (1=Disagree strongly; 6=Agree strongly); average scores range from 1 to 6, with higher scores indicating better outcomes.
  • Self-Efficacy for Parenting Tasks Index - Toddler Scale (SEPTI-TS): Routines Subscale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    The Self-Efficacy for Parenting Tasks Index - Toddler Scale - Short Form (SEPTI-TS-SF) is used to measure parents' self-efficacy for a discipline- and routines-related parenting tasks. The Routines subscales are measured with 6 items each. Respondents answer on a 6-point scale (1=Disagree strongly; 6=Agree strongly); average scores range from 1 to 6, with higher scores indicating better outcomes.
  • Engagement in Program-Targeted Parenting Practices (PTPP) - Parent's Self Efficacy Scale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    Parents' self-efficacy for engaging in the parenting practices targeted by the intervention is measured via the Engagement in Target Activities with Child measure, Parents' Self-Efficacy subscale. Created for this study, these number of items will be determined and will items ask parents to rate how confident they are that they know how to do a series of parenting practices targeted by the program, on a scale of 1 to 10 (1 = Not at all confident; 10 = Highly confident). Average scores range from 1 to 10, with higher scores indicating greater parental self-efficacy (better outcome).
  • Engagement in Program-Targeted Parenting Practices (PTPP) - Frequency Subscale — T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
    The frequency of parents' engagement in the parenting practices targeted by the intervention is measured via the Engagement in Target Activities with Child measure, Frequency subscale. Created for this study, the number of items will be determined and will ask parents to report the frequency with which they have engaged in target parenting practices in the past 4 weeks. Parents report their frequency on a 6-point scale (0 = "Never in the past month" to 5 = "Every day in past month:). Averaged scores range from 0 to 5, with higher scores indicating more frequent parental engagement in the target activities (better outcome).

Trial sites (1)

FacilityCityRegionStatus
Oregon Research Behavioral Intervention Strategies, Inc. Springfield Oregon

More Oregon Research Behavioral Intervention Strategies, Inc. trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07462052 on ClinicalTrials.gov ↗ ← All trials in the USA